Raptor Pharmaceutical Corp. (NASDAQ:RPTP) has made an exciting and potential quality of life changing announcement today for people afflicted with the hereditary brain disorder Huntington’s disease. Raptor Pharmaceutical Corp. (NASDAQ:RPTP) stock opened at $17.05 in last session, and closed at $17.14, while the day range of Raptor Pharmaceutical Corp. (NASDAQ:RPTP) stock is $16.33 – $17.72. The stock showed a positive weekly performance of 10.65%.
Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, announced that its preliminary estimate that, based on the Company’s current review of the last fiscal year’s results, its 2013 revenue growth is expected to exceed by 20% year over year while the Company expects to achieve breakeven or slightly profitable operating results as compared with a nearly USD$21.8 million loss from operations in 2012.
Biostar Pharmaceuticals Inc. (NASDAQ:BSPM) stock opened at $2.47 in last session, and closed at $2.49 by gaining 7.79%. The 52 week range of $0.62 – $3.44. Company’s market capitalization is $29.94M. Stock analysts at Oppenheimer upped their price objective on shares of Neurocrine Biosciences (NASDAQ:NBIX) from $15.00 to $19.00 in a report issued on Monday, 12 February 2014 Analyst Ratings Network.com reports.
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock increased 6.09% and finished the last session at $17.60. The EPS of the stock remained -0.39. Company’s market capitalization is $1.18B. Intercept Pharmaceuticals, Inc.(NASDAQ:ICPT) a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver and intestinal diseases, today announced that Mark Pruzanski, M.D., President and Chief Executive Officer, will present at theHealthcare and Cowen & Company’s 34th Annual Health Care Conference.
Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) stock opened the session at $358.14, and closed the session at $375.14. The 52 week range of the Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) stock remained $30.38 – $497.00 and the day range was $357.31 – $377.45.